Form 4: Arcellx Chief Medical Officer Christopher Heery Executes Stock Option and Sells Shares

Christopher Heery, Chief Medical Officer of Arcellx, Inc., exercised stock options and sold shares on September 5, 2024, according to a Form 4 filing with the SEC.

Summary

• On September 5, 2024, Christopher Heery, the Chief Medical Officer of Arcellx, Inc., exercised stock options to acquire 3,421 shares of common stock at a price of $15 per share.
• Simultaneously, Heery sold 3,421 shares of Arcellx common stock at a weighted average price of $70.0164, within a price range of $70.00 to $70.15.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2023.
• Following these transactions, Heery directly owns 9,278 shares of Arcellx common stock and 132,416 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine transactions by an officer under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares by a company officer, but the pre-planned nature of the sale mitigates concerns.

Key Dates